Prognostic value of the Memorial Sloan Kettering Prognostic Score in metastatic pancreatic adenocarcinoma.

Justin M LebenthalJunting ZhengPaul A GlareEileen M O'ReillyAndrew C YangAndrew S Epstein

Published in: Cancer (2021)

The Memorial Sloan Kettering Prognostic Score (MPS) is a new scoring system that incorporates markers of inflammation found in individuals' blood at the diagnosis of metastatic pancreatic cancer. Data suggest that the MPS may help to determine prognosis.

Keyphrases

squamous cell carcinoma
small cell lung cancer
oxidative stress
electronic health record
big data
machine learning
deep learning